Networked & Personalized - the future of biotech?
During BIO2012 last week, Ernst & Young presented their annual Beyond Borders report on the state of the biotech industry. Several themes are covered in the report but the underlying trend is a much broader discussion and movement towards open sharing of data and collaboration across academia, industry, patient advocacy groups and payors. This "networked innovation" aligns biotech with high tech's much broader use of data and personalized targeting that we see at work in social networks and online advertising every day and has enormous opportunity to increase timelines and success rates in drug development.
Barbara Lavery
|
June 25, 2012
Biotech
|
Personalized Medicine
|
Pharma
